Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction

被引:15
|
作者
Morgen, Camilla S. [1 ]
Haase, Christiane L. [1 ]
Oral, Tugce K. [1 ]
Schnecke, Volker [1 ]
Varbo, Anette [1 ]
Borlaug, Barry A. [2 ,3 ]
机构
[1] Novo Nord A S, Soborg, Denmark
[2] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[3] Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55902 USA
关键词
ADIPOSE-TISSUE;
D O I
10.1016/j.mayocp.2023.07.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare clinical features of patients with obesity-related heart failure (HF) with preserved ejection fraction (HFpEF) with those of patients with similar body mass index (BMI) but no HF and to examine the association between degree of obesity and risk for hospitalizations.Methods: This was a retrospective analysis of 22,750 adults from a large US electronic health care data set (January 1, 2012, through July 31, 2019), including 4975 with HFpEF. Baseline characteristics were compared between patients with HFpEF and a control group matched on BMI, age, sex, and year of BMI record. Risk of first hospitalization was analyzed in the HFpEF sample with negative binomial and Cox proportional hazards models, adjusted for baseline comorbidities.Results: Compared with controls without HF matched on BMI, age, sex, and year of BMI record, patients with HFpEF displayed worse kidney function, greater estimated plasma volume, and more cardiovascular comorbidities. Within the HFpEF cohort, patients with higher degree of obesity were younger and had fewer concomitant cardiovascular comorbidities than those with lower degree of obesity. The mean number of HF-related hospitalizations increased with higher degree of obesity (9.6 to 15.7/100 patient-years; P1/4.002), but higher degree of obesity was not associated with increased risk of non-HF-related hospitalizations.Conclusion: Among persons with obesity, increasing cardiorenal dysfunction and volume overload differentiate those with HFpEF. Among persons with established HFpEF, those with higher degree of obesity are younger and have fewer cardiovascular comorbidities but display a unique increased risk of HF-related hospitalizations, even as risk for other hospitalizations is not different.
引用
收藏
页码:1458 / 1468
页数:11
相关论文
共 50 条
  • [21] Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
    Yang, Eunice
    Vaishnav, Joban
    Song, Evelyn
    Lee, Joan
    Schulman, Steven
    Calkins, Hugh
    Berger, Ronald
    Russell, Stuart D.
    Sharma, Kavita
    ESC HEART FAILURE, 2022, 9 (05): : 3918 - 2927
  • [22] Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
    Packer, Milton
    Zile, Michael R.
    Kramer, Christopher M.
    Baum, Seth J.
    Litwin, Sheldon E.
    Menon, Venu
    Ge, Junbo
    Weerakkody, Govinda J.
    Ou, Yang
    Bunck, Mathijs C.
    Hurt, Karla C.
    Murakami, Masahiro
    Borlaug, Barry A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [23] Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
    Kirkman, Danielle L.
    Bohmke, Natalie
    Billingsley, Hayley E.
    Carbone, Salvatore
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [24] Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity
    Wagner, Jeffrey
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (25): : 2398 - 2398
  • [25] Ethnic Differences in Comorbidities Do Not Predict Risk for Heart Failure Readmissions in Hospitalized Patients with Heart Failure with Preserved Ejection Fraction
    Hsiao, Ruth
    Nghia Nguyen
    Narezkina, Anya
    Huang, Grace
    Zhang, Sherry
    Greenberg, Barry
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S76 - S76
  • [26] Skin Autofluorescence as a Predictor of First Heart Failure Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction
    Hitsumoto, Takashi
    CARDIOLOGY RESEARCH, 2020, 11 (04) : 247 - 255
  • [27] Spironolactone reduces the risk of mortality and hospitalization in veterans with heart failure with preserved ejection fraction
    Kurgansky, Katherine E.
    Parker, Rachel
    Djousse, Luc
    Joseph, Jacob
    Gagnon, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 564 - 565
  • [28] Predictors of Heart Failure Related Death or Hospitalization in Patients with Heart Failure due to Preserved Ejection Fraction
    Calvin, James E.
    Mangla, Ashvarya
    Beaty, Elijah
    Kane, John
    Richardson, Dejuran
    Powell, Lynda H.
    CIRCULATION, 2012, 126 (21)
  • [29] Risk factors for heart failure rehospitalization in patients with preserved ejection fraction : Comparison between preserved ejection fraction and reduced ejection fraction
    Setoguchi, M.
    Hashimoto, Y.
    Isobe, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S282 - S282
  • [30] The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction)
    Carson, Peter E.
    Anand, Inder S.
    Win, Sithu
    Rector, Thomas
    Haass, Markus
    Lopez-Sendon, Jose
    Miller, Alan
    Teerlink, John R.
    White, Michel
    McKelvie, Robert S.
    Komajda, Michel
    Zile, Michael R.
    McMurray, John J.
    Massie, Barry
    JACC-HEART FAILURE, 2015, 3 (06) : 429 - 441